Instituto D'Or de Pesquisa e Ensino - Sao Paulo
Instituto D'Or de Pesquisa e Ensino - Sao Paulo
Av. República do Líbano, 611 - Ibirapuera, São Paulo - SP, 04501-000
Select an option
I am a doctor
I am a sponsor
Open studies
Non-Hodgkin Lymphoma
A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma - GLOBRYTE - Hoffmann-La RocheSee more
Study to Compare the Effectiveness and Safety of Golcadomide Plus R-CHOP vs Placebo Plus R-CHOP in Participants With Previously Untreated High-risk Large B-cell Lymphoma - GOLSEEK-1 - CelgeneSee more
A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell Malignancies - CaDAnCe-101 - BeiGeneSee more
A Trial to Learn How Effective and Safe Odronextamab is Compared to Standard of Care for Adult Participants With Previously Treated Aggressive B-cell Non-Hodgkin Lymphoma - OLYMPIA-4 - Regeneron PharmaceuticalsSee more
Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Previously Untreated Follicular Lymphoma - EPCORE™FL-2 - AbbVieSee more
Leukemia
A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell Malignancies - CaDAnCe-101 - BeiGeneSee more
A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1) - cAMeLot-1 - Janssen Research & Development, LLCSee more
A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL) - CELESTIAL-RRCLL - German CLL Study GroupSee more
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML) - cAMeLot-2 - Janssen Research & Development, LLCSee more
Bladder Cancer
Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer - ADVANCED-2 - Protara TherapeuticsSee more
Breast Cancer
A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants With Early Breast Cancer - EMBER-4 - Eli Lilly and CompanySee more
Head and neck cancer
A Study to Test Whether Treatment With BI 770371 in Combination With Pembrolizumab With or Without Cetuximab Helps People With Head and Neck Cancer Compared With Pembrolizumab Alone - Boehringer IngelheimSee more
Lymphoma
A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell Malignancies - CaDAnCe-101 - BeiGeneSee more
Multiple myeloma
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide) - MagnetisMM-32 - PfizerSee more
Prostate cancer
A Phase 2 Trial of Darolutamide as a Prostate-Specific Membrane Antigen (PSMA) Expression Enhancer in Patients With Localized Prostate Cancer - Darolutamide - D'Or Institute for Research and EducationSee more
Rare diseases
A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell Malignancies - CaDAnCe-101 - BeiGeneSee more
